CHICAGO — JAMA and the JAMA Network announced today that Kirsten Bibbins-Domingo, PhD, MD, MAS, has extended her contract with the American Medical Association (AMA) through 2031, providing continuity in the leadership one of the world's leading medical publishing platforms.
An acclaimed and highly accomplished physician-scientist and academic leader, Dr. Bibbins-Domingo joined the JAMA Network in 2022 from the University of California, San Francisco (UCSF), where she is currently on leave. She is Professor of Epidemiology and Biostatistics and the Lee Goldman, MD Professor of Medicine at UCSF, as well as an attending general internist at Zuckerberg San Francisco General Hospital, where she continues to see patients.
“Kirsten is an exceptional leader for JAMA . She honors the journal's extraordinary legacy while bringing fresh perspective, intellectual rigor, and a deep commitment to advancing medicine through trusted science. Under her guidance, JAMA has strengthened its influence around the world and remained an indispensable resource for physicians, researchers, and health leaders," said AMA CEO John Whyte, MD, MPH.
Published continuously since 1883, JAMA is one of the most widely circulated, peer-reviewed medical journals in the world. With a Journal Impact Factor of 65.4, JAMA ranks third among medical and scientific journals publishing original research. The JAMA Network brings JAMA together with JAMA Network Open and 11 specialty journals, each of which is a top-tier publication in its respective field, making the JAMA Network an unparalleled platform for impactful scientific research, educational content, and opinion that is shaping the future of medicine.
Under Dr. Bibbins-Domingo, the JAMA Network has launched several initiatives designed to expand engagement, strengthen scientific communication, and support the next generation of medical researchers and authors, including:
“Serving as Editor in Chief of JAMA and the JAMA Network over the past four years has been tremendously rewarding, and I am honored to continue leading this preeminent network of medical journals,” said Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA and the JAMA Network. “At this time of rapid change in medicine, the need for rigorous and trusted science has never been greater. I look forward to building on our legacy of excellence and ensuring that JAMA and the JAMA Network remain an essential resource for clinicians, researchers, and policymakers worldwide.”
For more information, contact JAMA Network Media Relations at mediarelations@jamanetwork.org